Opko Health OPK
NASDAQ OPK
$1.73 +0.04 (+2.41%)
As of: Sep 22, 2026 · 10:07 AM EDT

Opko Health (OPK) Profit After Tax (2010 - 2026)

Opko Health's (OPK) quarterly Profit After Tax came in at -$8.4 million in Q2 2026, up 94.33% on a YoY basis from -$4.3 million in Q2 2025, and up 84.66% quarter-over-quarter from -$54.8 million in Q1 2026.

Analysis

Opko Health (OPK) Profit After Tax (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Profit After Tax for 17 consecutive years, with -$8.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Profit After Tax rose 94.33% year-over-year to -$8.4 million; the trailing twelve-month figure through Jun 2026 stood at -$72.9 million (up 72.93% YoY), and the FY2025 full-year result was -$225.7 million, down 324.02% from the prior year.
  • Profit After Tax improved to -$8.4 million in Q2 2026 per OPK's latest filing, from -$54.8 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $21.6 million in Q3 2025 and bottomed at -$148.4 million in Q2 2025.
  • Historically, Profit After Tax has averaged -$57.4 million across 5 years, with a median of -$66.9 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Profit After Tax tumbled 528.01% in 2022, then jumped 132.16% in 2025.
  • Over 5 years, Profit After Tax stood at -$85.2 million in 2022, then grew by 22.0% to -$66.5 million in 2023, then jumped by 121.1% to $14.0 million in 2024, then tumbled by 322.83% to -$31.3 million in 2025, then soared by 73.07% to -$8.4 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$8.4 million, -$54.8 million, and -$31.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 5.53 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.62 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 3.26 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -248.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 3.40 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 438.21 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -644.37 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 237.01 Mn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -8.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.42 Mn
Mar 31, 2026 -54.85 Mn
Dec 31, 2025 -31.26 Mn
Sep 30, 2025 21.63 Mn
Jun 30, 2025 -148.44 Mn
Mar 31, 2025 -67.61 Mn
Dec 31, 2024 14.03 Mn
Sep 30, 2024 -67.25 Mn
Jun 30, 2024 -92.14 Mn
Mar 31, 2024 -81.84 Mn
Dec 31, 2023 -66.48 Mn
Sep 30, 2023 -84.47 Mn
Jun 30, 2023 -19.64 Mn
Mar 31, 2023 -18.27 Mn
Dec 31, 2022 -85.23 Mn
Sep 30, 2022 -86.09 Mn
Jun 30, 2022 -101.65 Mn
Mar 31, 2022 -55.43 Mn
Dec 31, 2021 -73.78 Mn
Sep 30, 2021 28.74 Mn
API Access

Opko Health Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=OPK&period=max&api_key=YOUR_API_KEY